Biolase inc.

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. Our award-winning dental lasers …BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications.Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including …IRVINE, Calif., Nov. 13, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has entered into a $12.5 million senior secured term loan agreement with SWK Funding LLC. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a Dallas, Texas-based healthcare focused investment firm.

Prior to joining BIOLASE, Brown was a co-founder of Kreativ, Inc., an international advanced dental equipment company, from 1995 until it was acquired in 1999 by Welch-Allyn, Inc., at which time he served as Director of New Product Development and Board Director for Welch-Allyn Kreativ, Inc. until 2002.

A company with a name that ends in “inc.” is incorporated, giving its owners, officers and investors specific legal advantages. Essentially, these key people in the business have no personal liability in the event that the business fails or...IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that investors, including the Jack W. Schuler Living Trust, Oracle Partners, L.P. and Oracle Institutional Partners L.P., and certain BIOLASE directors and officers, have agreed to purchase $10 million of unregistered …

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live ...9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...BIOLASE's proprietary laser products incorporate approximately 302 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain ...IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, completed its leadership council meeting of the Waterlase Endo Academy on Nov. 14, forming an exclusive community of leading endodontists, dedicated to improving patient outcomes and profitability with new technology. The academy, open to …Intuitive Education.Biolase.com Portal Will Ensure Positive User Experience. LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and educational initiatives with the launch of its new education web portal, …

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...

BIOLASE's proprietary laser products incorporate approximately 302 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain ...

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2022, and to answer questions. To access the live call, dial 1-877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following code: 838343.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada ...9 nov 2023 ... All trademarks and brand name are the property of their respective companies. Company Overview. BIOLASE, Inc. is a medical device company that ...BIOLASE, Inc. (“BIOLASE” and, together with its consolidated subsidiaries, the “Company,” “we,” “our” or “us”) is a leading provider of advanced laser systems for the dental industry. We develop, manufacture, market, and sell laser systems that provide significant benefits for dental practitioners and their patients.Biolase Mucocele Removal Protocol. Follow. from BIOLASE, Inc. 2 years ago — via Parallel Uploader. Recommended; Description; Comments.Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. IRVINE, Calif., June 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately $6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to …

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Jun 15, 2023 6:30am EDT. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Feb 6, 2021 · BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies ... View and filter SEC Filings by group or type. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….Includes Net Income, Adjustments, and Cash flows from investig & financing activities. View Cash Flow. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

BIOLASE's Board of Directors unanimously recommends that stockholders vote "FOR" the amendment to the BIOLASE, Inc. Certificate of Incorporation to effect a reverse stock split (without reducing the authorized number of shares of common stock). The text of the letter is as follows: ***** October 27, 2021. Dear Fellow Stockholders:FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. Our award-winning dental lasers enable dentists and...May 11, 2023 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live ... Dental Laser Procedures & Treatments. BIOLASE award-winning all-tissue and soft-tissue dental lasers are used for minimally invasive procedures and treatments including Endodontics, Periodontics, Dental Implants, Restorative Dentistry, Soft Tissue, and more. Dentists & Laser Dentistry. Hygienists.LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising ...IRVINE, Calif., Nov. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has launched the Epic Hygiene Academy, bringing together leaders in the dental hygiene profession to provide improved continuing education and support the delivery of superior patient care through laser technology.Find international BIOLASE distributors in Italy, Russia, Bulgaria, Spain, Spain, France, Poland, Germany, Ukraine, UK, Greece, and elsewhere.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2021 and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in ...BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies ...

IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, completed its leadership council meeting of the Waterlase Endo Academy on Nov. 14, forming an exclusive community of leading endodontists, dedicated to improving patient outcomes and profitability with new technology. The academy, open to …

BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and …

As pet owners, we want to keep our furry friends safe and secure. Invisible Fence Inc. has been providing pet owners with innovative solutions to keep their pets out of harm’s way for over 40 years. With their advanced technology, Invisible...BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed ...BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. , a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000...BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and …Q4 2022 Financial Results Conference Call. Mar 28, 2023 • 4:30 pm EDT. To access the call replay dial 877-481-4010 or +1 919-882-2331 (International) and enter replay passcode 47764. Earnings Release. PDF HTML.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 720380.150 Royall St. Suite V. Canton MA 02021. Under the rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each warrant issued in a private placement transaction that was consummated on June 10, 2020 (on an as-if-converted-to-common-stock basis) held on the Record Date (July 1, …FOOTHILL RANCH, Calif., May 9, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that Kenneth P. Yale, D.D.S., J.D. was newly elected to its Board of Directors (the "Board"), effective April 28, 2022. Dr. Yale, along with other recently elected Board members, Drs. Kathleen T. …http://www.biolase.comBIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser ...BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine.BIOLASE, Inc. is a biomedical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers.

Orbit Irrigation Products, Inc. commonly referred to as simply Orbit, produces irrigation products for residential and commercial home and garden use. Occasionally, you may need to reference one of Orbit’s product manuals for the proper use...BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%. View the latest Biolase Inc. (BIOL) stock price, news, historical charts, analyst ratings and financial information from WSJ.Instagram:https://instagram. mandt first time home buyerinteractive broker vs td ameritradeonline bank account with virtual debit cardbyd shares BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…LAKE FOREST, Calif., Nov. 7, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ... gls 600 maybach pricebest podcasts for female entrepreneurs BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year.Apple Inc. employs 115,000 employees worldwide, with most being in the U.S. Many other jobs are attributable to Apple, including 627,000 created to support the iOS ecosystem. The company has 478 retail locations worldwide. how to do option trading on webull BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live call, dial 1-877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following code: 180082.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…